Definition of poorly differentiated carcinoma of the thyroid: The Japanese experience

Endocrine Pathology

Volumn 15, Issue 4, 2004, Pages 307-311

  Sakamoto, Atsuhiko ^a,b  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE   (Japan)

Author keywords

Aggressive cancer; Definition; Histology; Poorly differentiated carcinoma; Thyroid cancer

Indexed keywords

ADULT; ANAPLASTIC CARCINOMA; CANCER CLASSIFICATION; CONFERENCE PAPER; FEMALE; HISTOLOGY; HUMAN; JAPAN; MALE; PRIORITY JOURNAL; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; TUMOR DIFFERENTIATION;

ADENOCARCINOMA, FOLLICULAR; ADENOCARCINOMA, PAPILLARY; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; HUMANS; TERMINOLOGY; THYROID GLAND; THYROID NEOPLASMS;

EID: 13444292976     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1385/EP:15:4:307     Document Type: Conference Paper

References (21)

1. Donohue JH, Goldfien SD, Miller TR. Do the prognoses of papillary and follicular carcinomas differ? Am J Surg 148:168-173, 1984.
2. Franssila KO. Is the differentiation between papillary and follicular thyroid carcinoma valid? Cancer 32:853-864, 1973.
3. Sakamoto A, Kasai N, Sugano H. Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas. Cancer 52:1849-1855, 1983.
4. Dobashi Y, Sakamoto A, Sugimura H, et al. Overexpression of p53 as a possible prognostic factor in human thyroid carcinomas. Am J Surg Pathol 17:375-381, 1993.
5. Dobashi Y, Sugimura H, Sakamoto A, et al. Stepwise participation of p53 gene mutation during dedifferentiation of human thyroid carcinomas. Diagn Mol Pathol 3:1-14, 1994.
6. Nishida T, Katayama S, Tsujimoto M, Nakamura J, Matsuda H. Clinicopathological significance of poorly differentiated thyroid carcinoma. Am J Surg Pathol 23:205-211, 1999.
7. Byar DP, Green SB, Dor P. A prognostic index for thyroid carcinoma: a study of the EORTC Thyroid Cancer CO-operative Group. Eur J Cancer 15:1033-1041, 1979.
8. Carcangiu ML, Zampi G, Rosai J. Poorly differentiated (insular) thyroid carcinoma: a reinterpretation of Langerhans' "wuchende Struma." Am J Surg Pathol 8:665-668, 1984.
9. Evans HL. Columnar-cell carcinoma of the thyroid. A report of two cases of an aggressive variant of thyroid carcinoma. Am J Clin Pathol 85:77-80, 1986.
10. Johnson TL, Lloyd RV, Thompson NW, Beierwaltes WH, Sisson JC. Prognostic implications of the tall cell variant of papillary thyroid carcinoma. Am J Surg Pathol 12:22-27, 1988.
11. Sasaki A, Daa T, Kashima K, Yokoyama S, Nakayama I, Noguchi S. Insular component as a risk factor of thyroid carcinoma. Pathol Int. 46:939-946, 1996.
12. Sobrinho-Simoes M, Nesland JM, Johannessen JV. Columnar-cell carcinoma. Another variant of poorly differentiated carcinoma of the thyroid. Am J Clin Pathol 89:264-267, 1998.
13. Yamamoto Y, Izumi K, Otsuka H. An immunohistochemical study of epithelial membrane antigen, cytokeratin and vimentinin papillary thyroid carcinoma. Recognition of lethal and favorable prognostic types. Cancer 70:2326-2333, 1992.
14. Donghi R, Longoni A, Pilotti S, Michieli P, Della Porta G, Pierotti MA. p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland. J Clin Invest 91:1753-1760, 1993.
15. Fagin JA, Matsuo K, Kamakar A, Chen DL, Tang SH, Koeffler HP. High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. J Clin Invest 91:179-184, 1993.
16. Ivanova R, Scares P, Castro P, Sobrinho-Simoes M. Diffuse (or multinodular) for follicular variant of papillary thyroid carcinoma: a clinicopathologic and immunohistochemical analysis of ten cases of an aggressive form of differentiated thyroid carcinoma. Virchows Arch 440:418-424, 2002.
17. Pilotti S, Collini P, Del Bo R, Cattoretti G, Pierotti MA, Filke F. A novel panel of antibodies that segregates immunocytochemically poorly differentiated carcinoma from undifferentiated carcinomas originating from the follicular epithelium of the thyroid gland. J Pathol 172:337-342, 1994.
18. Nikiforov YE, Erickson LA, Nikiforova MN, Caudill CM, Lloyd RV. Solid variant of papillary thyroid carcinoma: incidence, clinical-pathologic characteristics, molecular analysis, and biologic behavior. Am J Surg Pathol 25:1478-1484, 2001.
19. Nikiforava MN, Kimura ET, Gandhi M, et al. BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. Clin Endocrinol Metab 88:5399-5404, 2003.
20. Harach HR, Franssila KO. Thyroglobulin immunostaining in follicular thyroid carcinoma; relationship to the degree of differentiation and cell type. Histopathology 13: 43-54, 1998.
21. Oyama T, Suzuki T, Hara F, et al. N-ras mutation of thyroid tumor with special reference to follicular type. Pathol Int 45:45-50, 1995.